このアイテムのアクセス数: 157

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
s41467-022-28802-x.pdf2.14 MBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.authorFujita-Fujiharu, Yokoen
dc.contributor.authorSugita, Yukihikoen
dc.contributor.authorTakamatsu, Yukien
dc.contributor.authorHouri, Kazuyaen
dc.contributor.authorIgarashi, Manabuen
dc.contributor.authorMuramoto, Yukikoen
dc.contributor.authorNakano, Masahiroen
dc.contributor.authorTsunoda, Yugoen
dc.contributor.authorTaniguchi, Ichiroen
dc.contributor.authorBecker, Stephanen
dc.contributor.authorNoda, Takeshien
dc.contributor.alternative藤田, 陽子ja
dc.contributor.alternative杉田, 征彦ja
dc.contributor.alternative高松, 由基ja
dc.contributor.alternative祝部, 和也ja
dc.contributor.alternative五十嵐, 学ja
dc.contributor.alternative村本, 裕紀子ja
dc.contributor.alternative中野, 雅博ja
dc.contributor.alternative角田, 優伍ja
dc.contributor.alternative谷口, 一郎ja
dc.contributor.alternative野田, 岳志ja
dc.date.accessioned2022-03-08T05:32:55Z-
dc.date.available2022-03-08T05:32:55Z-
dc.date.issued2022-
dc.identifier.urihttp://hdl.handle.net/2433/268713-
dc.description致死的な出血熱を引き起こすマールブルグウイルスの増殖機構を解明 --エボラ・マールブルグウイルスの創薬に期待--. 京都大学プレスリリース. 2022-03-07.ja
dc.descriptionViruses of a feather: Similar structures in Marburg and Ebola viruses provide clues for antivirals. 京都大学プレスリリース. 2022-07-25.en
dc.description.abstractThe nucleoprotein (NP) of Marburg virus (MARV), a close relative of Ebola virus (EBOV), encapsidates the single-stranded, negative-sense viral genomic RNA (vRNA) to form the helical NP–RNA complex. The NP–RNA complex constitutes the core structure for the assembly of the nucleocapsid that is responsible for viral RNA synthesis. Although appropriate interactions among NPs and RNA are required for the formation of nucleocapsid, the structural basis of the helical assembly remains largely elusive. Here, we show the structure of the MARV NP–RNA complex determined using cryo-electron microscopy at a resolution of 3.1 Å. The structures of the asymmetric unit, a complex of an NP and six RNA nucleotides, was very similar to that of EBOV, suggesting that both viruses share common mechanisms for the nucleocapsid formation. Structure-based mutational analysis of both MARV and EBOV NPs identified key residues for helical assembly and subsequent viral RNA synthesis. Importantly, most of the residues identified were conserved in both viruses. These findings provide a structural basis for understanding the nucleocapsid formation and contribute to the development of novel antivirals against MARV and EBOV.en
dc.language.isoeng-
dc.publisherSpringer Natureen
dc.rights© The Author(s) 2022en
dc.rightsThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.en
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/-
dc.subjectEbola virusen
dc.subjectMarburg virusen
dc.titleStructural insight into Marburg virus nucleoprotein–RNA complex formationen
dc.typejournal article-
dc.type.niitypeJournal Article-
dc.identifier.jtitleNature Communicationsen
dc.identifier.volume13-
dc.relation.doi10.1038/s41467-022-28802-x-
dc.textversionpublisher-
dc.identifier.artnum1191-
dc.addressLaboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University; Laboratory of Ultrastructural Virology, Graduate School of Biostudies, Kyoto University; CREST, Japan Science and Technology Agencyen
dc.addressLaboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University; Laboratory of Ultrastructural Virology, Graduate School of Biostudies, Kyoto University; Hakubi Center for Advanced Research, Kyoto Universityen
dc.addressLaboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University; Present address: Department of Virology I, National Institute of Infectious Diseasesen
dc.addressLaboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University; Laboratory of Ultrastructural Virology, Graduate School of Biostudies, Kyoto University; CREST, Japan Science and Technology Agencyen
dc.addressDivision of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido Universityen
dc.addressLaboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University; Laboratory of Ultrastructural Virology, Graduate School of Biostudies, Kyoto University; CREST, Japan Science and Technology Agencyen
dc.addressLaboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University; Laboratory of Ultrastructural Virology, Graduate School of Biostudies, Kyoto University; CREST, Japan Science and Technology Agencyen
dc.addressLaboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University; Laboratory of Ultrastructural Virology, Graduate School of Biostudies, Kyoto University; CREST, Japan Science and Technology Agencyen
dc.addressLaboratory of RNA system, Institute for Frontier Life and Medical Sciences, Kyoto Universityen
dc.addressInstitute of Virology, University of Marburg; German Center for Infection Research (DZIF), Marburg-Gießen-Langen Site, University of Marburgen
dc.addressLaboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University; Laboratory of Ultrastructural Virology, Graduate School of Biostudies, Kyoto University; CREST, Japan Science and Technology Agencyen
dc.identifier.pmid35246537-
dc.relation.urlhttps://www.kyoto-u.ac.jp/ja/research-news/2022-03-07-
dc.relation.urlhttps://www.kyoto-u.ac.jp/en/research-news/2022-07-25-
dcterms.accessRightsopen access-
datacite.awardNumber21J12207-
datacite.awardNumber21K07052-
datacite.awardNumber19K16666-
datacite.awardNumber20H03140-
datacite.awardNumber20H03494-
datacite.awardNumber19K22529-
datacite.awardNumber19H04831-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-21J12207/-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-21K07052/-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-19K16666/-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-20H03140/-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-20H03494/-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-19K22529/-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/ja/grant/KAKENHI-PUBLICLY-19H04831/-
dc.identifier.eissn2041-1723-
jpcoar.funderName日本学術振興会ja
jpcoar.funderName日本学術振興会ja
jpcoar.funderName日本学術振興会ja
jpcoar.funderName日本学術振興会ja
jpcoar.funderName日本学術振興会ja
jpcoar.funderName日本学術振興会ja
jpcoar.funderName日本学術振興会ja
jpcoar.awardTitleクライオ電子顕微鏡によるエボラウイルスヌクレオカプシドの構造解析ja
jpcoar.awardTitleフィロウイルス粒子形成および転写・複製の構造基盤ja
jpcoar.awardTitle組換えウイルスを用いたエボラウイルスポリメラーゼ複合体の微細構造解析ja
jpcoar.awardTitle汎フィロウイルス治療薬開発に向けたドライ-ウェット融合型研究基盤の構築ja
jpcoar.awardTitleインフルエンザウイルスの核内複製機構に関する研究ja
jpcoar.awardTitleウイルスゲノム間相互作用の立証と解明ja
jpcoar.awardTitleアレナウイルスの持続感染機構の分子基盤ja
出現コレクション:学術雑誌掲載論文等

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス Creative Commons